GlassScriptPhysician profile
Adam Michael Brouillard
NPI 1427578558
$38,362.50
in general payments reported to CMS, 2019-2025
43 companies · $2,785 in 2025
The $2,785 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2020: $593 · 2021: $1,954 · 2022: $3,832 · 2023: $13K · 2024: $16K · 2025: $2,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $10K · Consulting Fee: $7,575 · Grant: $2,000 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,368.96 |
| Travel and Lodging | $10,037.33 |
| Consulting Fee | $7,575.00 |
| Grant | $2,000.00 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,326.51 | 2021-2025 | Supera, Optis, Perclose Prostyle |
| Silk Road Medical, INC. | $8,424.13 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Edwards Lifesciences Corporation | $3,057.79 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $2,987.11 | 2021-2024 | Corevalve Evolut R, Venaseal |
| Boston Scientific Corporation | $2,275.83 | 2021-2025 | Angiojet Ultra 5000a, Ranger, General - Balloon Catheters |
| Penumbra, INC. | $1,540.47 | 2024 | Indigo System |
| Inari Medical, INC. | $937.40 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $690.41 | 2021-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Cardioform Septal Occluder |
| Actelion Pharmaceuticals US, INC. | $502.44 | 2020-2024 | Uptravi, Opsumit |
| Bard Peripheral Vascular, INC. | $440.88 | 2023-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Crosser Iq |
| Astellas Pharma US INC | $424.15 | 2020-2021 | |
| Endologix LLC | $388.41 | 2025 | Endocross Device, Torus Stent Graft System |
| Cardiovascular Systems INC. | $335.69 | 2020-2023 | Diamondback Peripheral |
| Pfizer INC. | $335.65 | 2021-2024 | |
| Cook Medical LLC | $318.38 | 2025 | Zilver Ptx |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $306.38 | 2020-2024 | Repatha |
| Impulse Dynamics (USA) INC. | $293.07 | 2022-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $256.80 | 2020-2021 | |
| Terumo Medical Corporation | $237.94 | 2024 | Glidesheath Slender, Heartrail, Azur Cx Detachable |
| Cardiva Medical, INC. | $233.92 | 2023-2024 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Novartis Pharmaceuticals Corporation | $178.38 | 2021-2024 | |
| Angiodynamics, INC. | $167.02 | 2025 | Alphavac |
| Shockwave Medical, INC | $150.95 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $148.10 | 2021-2022 | |
| Avinger INC. | $142.99 | 2023 | Pantheris |
| Sanofi-Aventis U.S. LLC | $141.50 | 2022-2023 | |
| Chiesi USA, INC. | $125.65 | 2020-2022 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Abiomed | $124.82 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $119.31 | 2020-2022 | |
| Philips North America LLC | $111.36 | 2023 | |
| Haemonetics Corporation | $101.56 | 2023 | |
| Surmodics, INC. | $96.05 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Janssen Pharmaceuticals, INC | $86.66 | 2021-2023 | Xarelto |
| Medtronic Vascular, INC. | $62.39 | 2020 | |
| Cardinal Health 200 LLC | $27.80 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.88 | 2022 | |
| Cordis US Corp. | $24.38 | 2023 | Outback Elite |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.52 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $18.69 | 2023 | Arcalyst |
| Contego Medical, INC | $18.50 | 2024 | |
| Verge Medical, INC. | $14.83 | 2021 | |
| Baylis Medical Company INC | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$149.16 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Brouillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.